How a dose of Aspirin can help to halt Cancer

The unassuming painkiller aspirin may hold the key to combating cancer as scientists in Australia have uncovered its ability to halt the spread of tumors. This groundbreaking discovery sheds light on the mysterious mechanism through which the widely available over-the-counter drug effectively inhibits the progression of the disease, potentially paving the way for transformative treatments and, ultimately, a cure.

Lead researcher Dr. Tara Karnezis from the Peter MacCallum Cancer Centre expressed optimism about the findings, stating, “I hope this information is one bit of the puzzle that will lead to a cure for cancer.” Aspirin, classified as a non-steroidal anti-inflammatory drug (NSAID), has long been recognized for reducing mortality rates associated with various common cancers, including those affecting the stomach, bowel, esophagus, pancreas, lungs, prostate, bladder, breast, and kidneys. However, the precise mechanism of its efficacy remained elusive.

The Australian research team uncovered that cancer tumors secrete proteins and growth factors that attract blood and lymphatic vessels to their vicinity, facilitating the flourishing and spreading of cancer cells. Importantly, these growth factors contribute to the widening of lymphatic vessels, acting as “supply lines” for cancer dissemination.

Dr. Karnezis highlighted that NSAID drugs, including aspirin, can counteract this widening process, impeding the spread of the disease. She explained, “A group of drugs reverse the widening of the supply line and make it hard for the tumor to spread. At the end of the day, that’s what kills people.”

This discovery opens avenues for the development of potent new therapies targeting the lymphatic vessel pathway, effectively restricting a tumor’s supply lines and limiting the transport of cancer cells throughout the body. While cancer specialists may currently incorporate aspirin into patient treatments, this breakthrough is expected to lead to the creation of more advanced and efficient drugs.

Associate Professor Steven Stacker, senior author of the study published in the journal Cancer Cell, elucidated the significance of the research, noting that tumors release growth factors that link to the prostaglandin cellular pathway. This pathway is associated with inflammation and vessel dilation throughout the body. Stacker emphasized, “The potential is incredibly exciting, as these new and improved drugs could help contain many solid epithelial tumors, including breast and prostate cancer, which affect large numbers of men and women.”

Beyond the immediate therapeutic implications, the research findings also suggest potential applications in cancer care as an “early warning system” before the spread of a primary tumor, marking a significant advancement in the ongoing battle against cancer.

RELATED ARTICLES

• Researchers Warn Vaping is just as Harmful as Cigarettes
• WEF Scientists Warn Next Pandemic Will 'Kill Billions'
• Australians Facing Unprecedented Rise in Mortality Rates, But Leaders Stay Silent
• Spike Protein Makes Women 'Infertile', Scientists Warn
• Scientists Have Recreated World's Deadliest Flu Virus